{
    "2021-07-27": [
        [
            {
                "time": "",
                "original_text": "成功避险？葛兰、赵诣等“顶流”基金经理或已调仓",
                "features": {
                    "keywords": [
                        "顶流",
                        "基金经理",
                        "调仓"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "行业观察|医药外包止跌回升背后：头部大企业绩纷纷高增CXO行业未来预期到底如何？",
                "features": {
                    "keywords": [
                        "医药外包",
                        "止跌回升",
                        "头部企业",
                        "CXO",
                        "高增"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "黄金赛道CXO|泰格医药：国内临床CRO王者，亦是“投资大佬”？",
                "features": {
                    "keywords": [
                        "黄金赛道",
                        "CXO",
                        "泰格医药",
                        "CRO",
                        "投资大佬"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】泰格医药(03347.HK)跌3.15%",
                "features": {
                    "keywords": [
                        "异动股",
                        "泰格医药",
                        "跌3.15%"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}